ROYAL BANK OF CANADA - MAIA BIOTECHNOLOGY INC ownership

MAIA BIOTECHNOLOGY INC's ticker is and the CUSIP is 552641102. A total of 10 filers reported holding MAIA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MAIA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$0270.0%0.00%
Q2 2023$027
+22.7%
0.00%
Q3 2022$0220.00%
Other shareholders
MAIA BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 35,000$77,0000.10%
Centric Wealth Management 64,456$142,4480.06%
Naviter Wealth, LLC 22,168$48,7700.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 26,600$58,5200.00%
WELLS FARGO & COMPANY/MN 34$750.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 33,987$74,7710.00%
BlackRock Inc. 8,017$17,6380.00%
Citadel Advisors 23,387$51,4510.00%
Tower Research Capital LLC (TRC) 3,962$8,7160.00%
View complete list of MAIA BIOTECHNOLOGY INC shareholders